Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...

Toxoplasmosis

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Transvaginal cervical cerclage: double monofilament modified Wurm vs single braided McDonald technique.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025

Same author

Locally advanced squamous cervical carcinoma (M0): management and emerging therapeutic options in the precision radiotherapy era.

Japanese journal of radiology·2023

Same author

[Twin pregnancy and polymalformative syndrome by Enterovirus].

Revue medicale de Liege·2020

Same author

[Kingella kingae bone and joint infections].

Revue medicale de Liege·2019

Same author

[Leptospirosis in a paperless migrant living in Brussels].

Revue medicale de Liege·2019

Same author

[How I explore... a suspicion of paracetamol allergy in children].

Revue medicale de Liege·2019

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

[Psittacosis without pulmonary symptoms at presentation].

M Sciacca¹, X Lombard, J P Longomba

¹CHR Citadelle, Liège, Belgique.

Revue Medicale De Liege

|November 17, 2009

Summary

Parrot fever (psittacosis) can initially mimic flu-like symptoms. Early diagnosis through patient history and serology is key, followed by antibiotic treatment like oral clarythromycin for recovery.

Area of Science:

Infectious Diseases
Zoonotic Diseases
Respiratory Medicine

Background:

Psittacosis, a zoonotic disease caused by Chlamydia psittaci, is transmitted from birds to humans.
Avian species, particularly parrots, are common reservoirs for Chlamydia psittaci.

Observation:

A patient presented with initial non-specific symptoms including headache, fever, and myalgia.
Pulmonary involvement, characterized by lesions on chest CT scans, manifested later in the disease course.
Exposure history, specifically cohabitation with parrots, was crucial for diagnostic suspicion.

Findings:

Serological analysis confirmed the diagnosis of psittacosis.
Treatment with specific antibiotics, including oral clarythromycin, proved successful.

Related Experiment Videos

Last Updated: Jun 18, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

The case highlights a delayed onset of respiratory symptoms in psittacosis.

Implications:

Emphasizes the importance of considering zoonotic infections in patients with relevant exposure history.
Underscores the diagnostic value of anamnesis and serological testing for psittacosis.
Demonstrates the efficacy of oral clarythromycin in treating psittacosis, even with delayed pulmonary manifestation.